Výsledky vyhledávání - "Leonard A. Kalman"

Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma: Results of a Phase II Study

Autor: William R. Berry, Leonard A. Kalman, Debra L. Litwak, Stephanie A. Gregory, Robert J. Belt, Alan Saven, Linda D. Bosserman, Delvyn C. Case

Publikováno v: Clinical Lymphoma. 4:93-98

The safety and efficacy of compressed-cycle (14-day) standard-dose CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) supported with prophylactic recombinant granulocyte colony-stimulating factor (G-CSF; filgrastim) were evaluated in patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de9b2b3f9037e934a0b0c026812cd99
https://doi.org/10.3816/clm.2003.n.017

Zobrazit plný text záznamu

Evaluating the efficacy of an advanced practice provider symptom management telephone triage program in reducing ED visits and 'avoidable' admissions of oncology patients

Autor: Leonard A. Kalman, Jorge Hirigoyen, Carmen Lazo, Jill Szymanski, Amy Malespin, Christopher Espinosa

Publikováno v: Journal of Clinical Oncology. 35:177-177

177 Background: One of the biggest challenges for oncology patients is timely access to care. The inability to provide the right care for the right patient at the right time many times result in overuse of Emergency Departments (ED) to receive oncolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7dc8d73c85e87f9dba58ce4355ac7acb
https://doi.org/10.1200/jco.2017.35.8_suppl.177

Zobrazit plný text záznamu

Carcinoma of unknown primary site

Autor: Leonard A. Kalman, F. Anthony Greco, Marshall T. Schreeder, Howard A. Burris, James R. Gray, Joan B. Erland, John D. Hainsworth

Publikováno v: Cancer. 89:2655-2660

BACKGROUND The long term survival and toxicity associated with the chemotherapy combination of paclitaxel, carboplatin, and extended-schedule etoposide used for the treatment of patients with metastatic carcinoma of unknown primary site were evaluate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd3facfd46d505491231f7699487d995
https://doi.org/10.1002/1097-0142(20001215)89:12<2655::aid-cncr19>3.0.co

Zobrazit plný text záznamu

Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients

Autor: Delvyn C. Case, Barbara J. Allen, Piyapong Vongkovit, Leonard A. Kalman, Moshe Fridman, Raul R. Mena, Christopher E. Desch

Publikováno v: Clinical lymphomamyeloma. 7(5)

Background: Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4364be88769b77bed1ea61e33bccf441
https://pubmed.ncbi.nlm.nih.gov/17562245

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání